Loading...
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MEDS’s FA Score shows that 0 FA rating(s) are green whileSSY’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MEDS’s TA Score shows that 2 TA indicator(s) are bullish.
MEDS (@Drugstore Chains) experienced а -7.36% price change this week, while SSY (@Drugstore Chains) price change was -6.15% for the same time period.
The average weekly price growth across all stocks in the @Drugstore Chains industry was +4.98%. For the same industry, the average monthly price growth was -9.59%, and the average quarterly price growth was -3.45%.
MEDS is expected to report earnings on Jul 24, 2023.
SSY is expected to report earnings on May 10, 2024.
The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.
MEDS | SSY | MEDS / SSY | |
Capitalization | 12.3M | 5.14M | 239% |
EBITDA | -2.68M | -3.03M | 88% |
Gain YTD | 58.213 | -34.409 | -169% |
P/E Ratio | N/A | 1.36 | - |
Revenue | 10.5M | 46.9M | 22% |
Total Cash | 34K | 2.06M | 2% |
Total Debt | 6.48M | 663K | 978% |
MEDS | SSY | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 51 | 82 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 99 Overvalued | 44 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 97 | |
PRICE GROWTH RATING 1..100 | 40 | 86 | |
P/E GROWTH RATING 1..100 | 99 | 98 | |
SEASONALITY SCORE 1..100 | 65 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SSY's Valuation (44) in the Hospital Or Nursing Management industry is somewhat better than the same rating for MEDS (99) in the null industry. This means that SSY’s stock grew somewhat faster than MEDS’s over the last 12 months.
SSY's Profit vs Risk Rating (100) in the Hospital Or Nursing Management industry is in the same range as MEDS (100) in the null industry. This means that SSY’s stock grew similarly to MEDS’s over the last 12 months.
SSY's SMR Rating (97) in the Hospital Or Nursing Management industry is in the same range as MEDS (98) in the null industry. This means that SSY’s stock grew similarly to MEDS’s over the last 12 months.
MEDS's Price Growth Rating (40) in the null industry is somewhat better than the same rating for SSY (86) in the Hospital Or Nursing Management industry. This means that MEDS’s stock grew somewhat faster than SSY’s over the last 12 months.
SSY's P/E Growth Rating (98) in the Hospital Or Nursing Management industry is in the same range as MEDS (99) in the null industry. This means that SSY’s stock grew similarly to MEDS’s over the last 12 months.
MEDS | |
---|---|
RSI ODDS (%) | 2 days ago75% |
Stochastic ODDS (%) | N/A |
Momentum ODDS (%) | N/A |
MACD ODDS (%) | N/A |
TrendWeek ODDS (%) | 2 days ago87% |
TrendMonth ODDS (%) | 2 days ago88% |
Advances ODDS (%) | N/A |
Declines ODDS (%) | 3 days ago90% |
BollingerBands ODDS (%) | 2 days ago72% |
Aroon ODDS (%) | 2 days ago90% |
A.I.dvisor tells us that MEDS and LFMD have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MEDS and LFMD's prices will move in lockstep.
Ticker / NAME | Correlation To MEDS | 1D Price Change % | ||
---|---|---|---|---|
MEDS | 100% | +0.25% | ||
LFMD - MEDS | 22% Poorly correlated | -2.35% | ||
PETS - MEDS | 7% Poorly correlated | N/A | ||
LFLY - MEDS | 5% Poorly correlated | -5.66% | ||
SSY - MEDS | 4% Poorly correlated | +0.42% | ||
YI - MEDS | 4% Poorly correlated | +0.96% | ||
More |
A.I.dvisor tells us that SSY and CJJD have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SSY and CJJD's prices will move in lockstep.
Ticker / NAME | Correlation To SSY | 1D Price Change % | ||
---|---|---|---|---|
SSY | 100% | +0.42% | ||
CJJD - SSY | 9% Poorly correlated | -1.50% | ||
HITI - SSY | 5% Poorly correlated | -4.37% | ||
BIMI - SSY | 5% Poorly correlated | -1.68% | ||
WBA - SSY | 5% Poorly correlated | -2.20% | ||
MEDS - SSY | 3% Poorly correlated | +0.25% | ||
More |